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ABSTRACT
There is a need for effective therapeutic options for 
resistant patellar tendinopathy. Ultrasound (US)- guided 
arthroscopic debridement has demonstrated promising 
clinical results.
Objectives To prospectively evaluate pain, function, 
tendon structure and adverse events after US and colour 
Doppler (CD)- guided arthroscopic debridement for 
persistent painful patellar tendinopathy.
Materials and methods Twenty- three consecutive 
patients (19 males and 4 females, mean age 28 years 
(±8), symptom duration 25 months (±21)), who had 
failed conservative management including progressive 
loading, were included. US+CD and ultrasound tissue 
characterisation (UTC) examination verified the clinical 
diagnosis and quantified baseline tendon structure. 
Patients were treated with US+CD- guided arthroscopic 
debridement followed by a specific rehabilitation protocol. 
Outcomes were VISA- P score for pain and function and 
UTC for tendon structure. Adverse events were specifically 
elicited.
Results At 6- month follow- up, mean VISA- P score 
increased from 40 (±21.0) to 82 (±15) (mean deviation 
(MD)=42.0, 95% CI 32 to 53, d=2.4), while organised echo 
pixels (combined UTC type I+II) increased from 55.0% 
(±17.0) to 69.0% (±15.0) (MD=14.0, d=0.7, 95% CI 2 
to 21). Both outcomes exceeded minimum detectable 
change values. Twenty- one participants returned to their 
prediagnosis activity levels, and there were no significant 
adverse events.
Conclusions US- guided patellar tendon debridement for 
persistent patellar tendinopathy improved symptoms and 
tendon structure without complications at 6- month follow- 
up. A majority (21/23) of the patients returned to their 
preinjury activity level. Further studies with longer follow- 
ups, preferably randomised and controlled, are needed.
INTRODUCTION
Patellar tendinopathy is a common overuse 
condition and difficult to treat.1 2 Conserva-
tive management using loading regimens is 
first line treatment. Both painful eccentric 
quadriceps training3 4 and heavy- slow resis-
tance training5 have demonstrated promising 
results, but certain subgroups cannot return 
to full training and sports.6 7 Alternative 
loading programmes, such as isometric exer-
cise approaches8 9, and adjunct interventions 
such as Extracorporeal Shockwave Therapy10 
and injection therapy,11–15 have shown mixed 
and limited results.
Surgery is considered after failed 
conservative treatment, but traditional 
intratendinous approaches demonstrate 
varying and unreliable results.16 17 Using 
similar principles as polidocanol11 18 19 or 
high volume12 13 20–22 injection, interference 
with the peritendinous nerve and vessel rich 
region outside the deep (dorsal) aspect of 
the proximal patellar tendon,21 23 an US and 
DP- guided arthroscopic- debridement proce-
dure has demonstrated positive outcomes in 
four clinical studies.18 19 24–26
There is no clear relationship between 
changes in structure, pain and function in 
tendinopathy, with some therapies leading 
to improved pain and function without 
structural change27–29 while other therapies 
leading to improved structure with changes 
in pain.30 To evaluate structure, there is a 
lack of objectivity and reliability using 2D 
US+CD or MRI.31 Recently, ultrasound tissue 
characterisation (UTC) has been used to visu-
alise tendon structure and quantify tendon 
matrix integrity.32 33
This prospective case series aimed to 
establish outcomes post- US+DP- guided 
arthroscopic tendon debridement in 
What are the new findings
 ► Patellar tendinopathy is difficult to manage in active 
athletes.
 ► Conservative management is not always successful.
 ► Traditional surgery is no better than exercise therapy.
 ► Patellar tendon debridement has demonstrated 
promising results.
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participants with persistent painful patellar tendinop-
athy. Clinical status and function using the VISA- P, and 
tendon structure using UTC, was used for evaluation.
MATERIAL AND METHODS
Participants presenting with persistent painful patellar 
tendinopathy at Pure Sports Medicine (London, UK) 
between August 2013 and October 2017 and could be 
evaluated at 6 months, were included. There were 19 
males and 4 females (mean age 28.1 years, ±8.2) with a 
mean symptom duration of 24.8 months (±21.1). All had 
previously failed conservative management including 
progressive loading (eccentric training n=13; heavy 
slow resistance n=10) and intermediate interventions 
including injection therapy (cortisone n=8, high volume 
n=5, sclerosing polidocanol n=1) or shockwave therapy 
(n=10). All were active in sport including nine from 
rugby, five from endurance running, four from football 
and one from track and field, tennis, cricket, Gaelic foot-
ball and cross fit. Sixteen were elite athletes.
Ultrasound (US)+colour Doppler (CD) (GE logic E10) 
was performed using a high frequency linear probe (MHz 
6–15) with the participant in supine position with the 
knee extended. In all subjects, US+CD showed a thick-
ened proximal patellar tendon with irregular structure 
mainly deep and central in the tendon, including focal 
hypoechoic regions and high blood flow arising from the 
Hoffa’s fat pad and infiltrating into the focal hypoechoic 
regions. There were also changes on the superficial 
side of the tendon in 17 cases demonstrating localised 
thickening of the paratenon including high blood flow 
figure 1. In four cases, there was a bony spur or calcifica-
tion distal to the inferior pole of the patella.
UTC was performed with participants in a seated posi-
tion with the foot on the floor and the knee flexed to 
100°. The transducer was placed perpendicular to the 
long axis of the tendon. Using UTC, the echo struc-
ture of the patellar tendon was quantified for a distance 
of 20 mm from the proximal insertion of the patellar 
tendon to the mid- portion of the tendon. Contours were 
performed on this region of interest prior to quantifica-
tion using a computer algorithm.32 33 Quantification was 
expressed as a percentage of organised and disorganised 
tissue with percentage of type I and II echopixels consis-
tent with organised tissue and type III and IV echopixels 
consistent with disorganised tendon tissue.
Surgical procedure
US+CD- guided arthroscopic tendon debridement was 
performed with general (n=5) or local anaesthesia 
(n=18). Participants were supine with extended knee. 
Standard anteromedial and anterolateral portals, 
pressure- controlled pump and no tourniquet were used. 
A routine arthroscopic evaluation of the knee joint was 
performed. Simultaneous US examination (longitudinal 
and transverse views) guided the procedure (figure 2). 
Careful debridement was performed using a 4.5 mm full 
radius blade shaver, aiming to remove vessels and nerves 
adjacent to the tendinopathic change on the deep side of 
the tendon (separating Hoffa’s fat pad from the patellar 
tendon) (figure 3). This technique is based on previous 
biopsy studies showing sensory and sympathetic nerves 
located close to blood vessels.21 23
If coexisting pathology was present such as bony spur 
or calcification at the inferior pole of the patella, careful 
excision using a shaver was performed. In these cases, it 
was necessary to also remove some tendinopathic tissue, 
but emphasis was placed on removal of less tendon tissue. 
The portals were sutured and 20 mL of local anaesthetic 
(Levobupivacaine 2.5 mg/mL) was injected into the knee 
joint.
Subsequently, the superficial part of the surgery 
was performed. The decision to perform a superficial 
scraping was based on focal superficial tendon tender-
ness on palpation together with abnormal US findings on 
the superficial aspect of the proximal patellar tendon. Via 
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a vertical longitudinal incision in the skin and bursa, the 
locally thickened paratenon was visualised (see figure 1). 
The richly vascularised fatty infiltration located under the 
paratenon on the superficial side of the tendon was care-
fully excised until normal underlying tendon tissue was 
visualised. Careful haemostasis was achieved. Resorbable 
sutures were used subcutaneously, and non- resorbable 
sutures were used for the skin. Local compression was 
applied.
Participants rested overnight and allowed to partially 
weight- bear with crutches. All participants were reviewed 
the next day. If a knee joint effusion was present, an aspi-
ration was performed under US- guidance using strict 
sterile conditions. In the absence of any postoperative 
complications such as a major superficial haematoma, 
rehabilitation was started using a specific postoperative 
rehabilitation plan (table 1). The general rehabilitation 
principles were derived from an expert consensus state-
ment on rehabilitation of patellar tendinopathy,7 but 
there was often a need to individualise the programme 
dependent on the functional requirements of the partic-
ipants. Sutures were removed at 3 weeks. All participants 
were reviewed at 6 months with clinical assessment and 
collection of VISA- P and UTC results.
Outcome measures
The primary outcome measure was the VISA- P, to 
evaluate the clinical outcome.34 This was completed inde-
pendently by the participant, in the absence of guidance 
from the treating clinician, at both baseline (preopera-
tive) and 6 months (postoperative).
The secondary outcome measure was tendon structure 
determined using UTC, measured by a single investigator 
(LM) at baseline and at 6 months.
Participants were instructed to report adverse events to 
a single investigator (LM).
All participants provided informed written consent for 
inclusion in the study.
Statistical analysis
Statistical testing was completed using Microsoft Excel 
for MacOS (Microsoft, Albuquerque, New Mexico, USA). 
Mean differences and associated 95% CIs were calcu-
lated for all variables to reflect postoperative outcomes. 
Figure 2 Surgical patellar tendon debridement procedure 
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In addition, a Cohen’s d was calculated to determine the 
size of identified interactions, interpreted as small (<0.2), 
moderate (>0.5) and large (>0.8), respectively.35
RESULTS
Primary outcome (participant function)
VISA- P scores increased from 40.0 (±21.0) at baseline to 
82.0 (±15.0) at 6- month follow- up (MD=42.0, d=2.4, 95% 
CI 32 to 53). In addition, 21/23 participants returned to 
their prediagnosis activity levels.
Secondary outcome (tendon structure)
Organised echo pixels (type I+II) increased from 55.0% 
(±17.0) at baseline to 69.0% (±15.0) at 6- month follow- up 
(MD=14.0%, d=0.7, 95% CI 2 to 21) (figure 4).
Adverse events
There was one knee joint effusion, presenting 1 day after 
the procedure. This hemarthrosis was aspirated under 
US guidance. There were no serious adverse events.
DISCUSSION
This case series demonstrated that US- guided patellar 
tendon debridement for recalcitrant patellar tendinop-
athy improves pain, function and tendon structure at 
6- month follow- up. A majority (21/23) of the partici-
pants returned to prediagnosis activity levels.
The most interesting finding in this study was the 
significantly improved tendon structure at 6 months 
after surgery. To the best of our knowledge, this finding 
has never previously been demonstrated after surgical 
patellar tendinopathy treatment. The relationship 
between tendon structure and symptoms is contro-
versial, particularly in relation to changes that occur 
following treatment. Some studies, using US and MRI, 
have reported no relationship between improvements in 
clinical symptoms and structural change.31 A more recent 
systematic review including more reliable imaging tech-
niques such as UTC found that there was an association 
between improvement in clinical symptoms and reduc-
tion in tendon thickness and neovascularisation.36 The 
current study used UTC to define changes in aligned 
fibrillar structure 6 months after surgery and demon-
strated significant improvement after arthroscopic 
patellar tendon debridement. Recent studies have shown 
that scanning of the patellar tendon in a similar position 
demonstrates good intrarater and inter- rater reliability, 
and intrarater minimal detectable change is estimated to 
be 5.5%.37
The cause for the improvement in tendon structure 
is unknown but could be directly related to this surgical 
technique. This debridement surgery uses US and 
CD to detect peritendinous regions with high blood 
flow. Seminal studies assessing biopsies from patellar 
tendinopathy tissue detected abnormal sensory and 
sympathetic neural infiltration in close relation to blood 
vessels in the peritendinous regions.21 23 Removing this 
abnormal neural ingrowth through US- guided tendon 
Table 1 Postoperative rehabilitation principles
Duration Rehabilitation principles
Week 1–2 Full weight bearing walking, range of motion exercises and quadriceps isometric exercises
Week 3–4 Introduction of closed- chain compound isotonic quadriceps exercises and proximal and distal kinetic chain 
strengthening
Week 5–8 Progression of strength training to achieve strength goals: as a general rule, participants aim to squat body 
weight and perform a single leg incline press at 1.5× body weight for at least eight repetitions per set
Week 9+ Introduction of plyometrics and sports specific training once strength goals achieved
Figure 4 Pre- UTC (above) and post- UTC (below) 
findings confirming increased organised (green) tissue 
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debridement could reduce pain and allow for more 
aggressive rehab with improvement in symptoms and 
structure. Alternatively, the positive effects of this surgery 
could be attributable to indirect effects of enforced rest 
and progressive rehab that would not have occurred if 
surgery had not been performed. Further studies using 
a reliable and quantifiable imaging modality, preferably 
with randomisation and an exercise control group, are 
required for more definitive conclusions to be drawn 
about the cause of structural improvement in this type of 
tendon surgery.
This surgical procedure is primarily extratendinous 
and differs substantially from more traditional intra-
tendinous surgical techniques.16 38 There are several 
advantages in using an extratendinous technique, the 
most important being that it allows for early full weight- 
bearing loading of the tendon. It could be argued 
that a randomised study comparing the US- guided 
arthroscopic debridement method with the traditional 
intratendinous revision surgery should be performed. 
However, this may raise issues since the results after 
intratendinous revision surgery has been shown to be 
poor and no better than non- operative treatment with 
eccentric training.16
The US+CD- guided arthroscopic debridement is the 
main surgical procedure during this treatment, but we 
also did a minor superficial debridement procedure. 
The justification for this superficial procedure is based 
on our findings that many subjects with longstanding 
symptoms have focal tenderness corresponding to US 
findings of localised thickening of the paratenon on the 
superficial surface of the proximal patellar tendon. Biop-
sies performed by our group (unpublished data) from 
this superficial tissue reveal richly vascularised fatty infil-
tration containing abnormal sensory and sympathetic 
nerves, which is similar innervation to the tissue on the 
deep aspect of the proximal patellar tendon.23 There-
fore, it seems appropriate to excise this tissue. However, 
the importance of this procedure to optimise clinical 
outcome should be evaluated in a randomised controlled 
trial.
This is a short- term follow- up study, but the positive 
clinical outcomes demonstrated with this method are 
not surprising since they are in keeping with results of 
a previous randomised controlled trial and a 4- year 
follow- up study19 25 26 on this procedure. In addition, this 
method appears to be safe.
A limitation of this study is the lack of a control 
group of enforced rest or exercise therapy. Therefore, 
the changes in pain, function and structure cannot be 
directly attributable to the surgical procedure but may 
be related to the indirect effects of surgery or natural 
history. However, as the majority of participants in this 
study had long duration of symptoms and reduced func-
tion unresponsive to loading regimens, it seems unlikely 
that the changes are entirely attributable to natural 
history.
CONCLUSION
US- guided patellar tendon debridement for persistent 
patellar tendinopathy improved symptoms and tendon 
structure without complications at 6- month follow- up. A 
majority (21/23) of the patients returned to their prein-
jury activity level. Further studies with longer follow- ups, 
preferably randomised and controlled, are needed.
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